Exhibit 107
Calculation of Filing Fee Tables
Form S-8
INOVIO PHARMACEUTICALS, INC.
(Exact Name of Registrant as Specified in its Charter)
| Security Type | Security Class Title | Fee Calculation Rule(3) | Amount Registered(1) | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price | Fee Rate | Amount of Fee(3) | |||||||
| Equity | Common Stock, $0.001 par value per share | 457(h) | 14,000,000 | $0.78(2) | $10,920,000.00 | 0.0001102 | $1,203.38 | |||||||
| Total Offering Amounts | $10,920,000.00 | $1,203.38 | ||||||||||||
| Total Fee Offsets | – | |||||||||||||
| Net Fee Due | $1,203.38 | |||||||||||||
| (1) | In accordance with Rule 416 under the Securities Act of 1933, as amended, this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. |
| (2) | Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended. The price per share and aggregate offering price are calculated on the basis of $0.78, the average of the high and low price of the registrant’s Common Stock as reported on the Nasdaq Global Select Market on May 15, 2023. |
| (3) | The Registrant does not have any fee offsets. |
